Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors.
Open Access
- 1 August 1998
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 102 (3) , 538-549
- https://doi.org/10.1172/jci1018
Abstract
Liver fibrosis results from the excessive secretion of matrix proteins by hepatic stellate cells (HSC), which proliferate during fibrotic liver injury. We have studied a model of spontaneous recovery from liver fibrosis to determine the biological mechanisms mediating resolution. Livers were harvested from rats at 0, 3, 7, and 28 d of spontaneous recovery from liver fibrosis induced by 4 wk of twice weekly intraperitoneal injections with CCl4. Hydroxyproline analysis and histology of liver sections indicated that the advanced septal fibrosis observed at time 0 (peak fibrosis) was remodeled over 28 d of recovery to levels close to control (untreated liver). alpha-Smooth muscle actin staining of liver sections demonstrated a 12-fold reduction in the number of activated HSC over the same time period with evidence of HSC apoptosis. Ribonuclease protection analysis of liver RNA extracted at each recovery time point demonstrated a rapid decrease in expression of the collagenase inhibitors TIMP-1 and TIMP-2, whereas collagenase mRNA expression remained at levels comparable to peak fibrosis. Collagenase activity in liver homogenates increased through recovery. We suggest that apoptosis of activated HSC may vitally contribute to resolution of fibrosis by acting as a mechanism for removing the cell population responsible for both producing fibrotic neomatrix and protecting this matrix from degradation via their production of TIMPs.Keywords
This publication has 31 references indexed in Scilit:
- Apoptosis and hepatobiliary diseaseHepatology, 1995
- Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis.Journal of Clinical Investigation, 1994
- Serum Collagenase Activity in Chronic Liver DiseasesPathology - Research and Practice, 1994
- Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomasJournal of Biological Chemistry, 1994
- Clinical evaluation of serum tissue inhibitor of metalloproteinases‐1 levels in patients with liver diseasesJournal of Gastroenterology and Hepatology, 1993
- Serum tissue inhibitor of metalloproteinases in patients with chronic liver disease and with hepatocellular carcinomaClinica Chimica Acta; International Journal of Clinical Chemistry, 1993
- The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment StrategiesNew England Journal of Medicine, 1993
- Cellular and molecular aspects of hepatic fibrosisThe Journal of Pathology, 1993
- Cooperative interaction between c-myc and bcl-2 proto-oncogenesNature, 1992
- Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1. Implications for regulation of matrix degradation in liver.Journal of Clinical Investigation, 1992